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Background:  Galectin-1 (Gal-1), a galactoside binding lectin, maintains T cell homeostasis, inhibits lymphocyte trafficking, and enhances 
production of Interleukin-10, actively participating in the resolution of inflammation. The role of Gal-1 in the healing process during acute myocardial 
infarction (AMI) is unknown. The aim was to evaluate the expression of Gal-1 in the myocardium in the mouse after AMI.
Methods:  Male CD-1 mice underwent experimental AMI by ligation of a coronary artery or sham surgery. Animals were sacrificed at 24 hs and 7 
days. Gal-1 protein levels were quantified through western blot (n=2 for each group), and localization was assessed through immunohistochemistry 
(n=2 for each time point).
Results:  The heart constitutively expressed Gal-1. The cardiac Gal-1 expression was unchanged 24 hs after AMI (see figure) whereas Gal-1 
expression was 7-fold higher than control 7 days after AMI. At immunohistochemistry Gal-1 was mainly localized in the infarct area with minimal or 
no staining in the remote myocardium. Gal-1 was expressed in mononuclear infiltrating cells, polymorphonuclears, and a mild staining was observed 
in cardiomyocites in the peri-infarct area but not in the remote area.
Conclusion:  Galectin-1 is constitutively expressed in heart and upregulated during the healing process of AMI (7 days), and may be responsible 
for the resolution of the inflammation in AMI. Exogenous galectin-1 administration may represent a mean to modulate the inflammatory response 
during AMI.
